Portal vein system thrombosis (PVST) is a frequent and potentially life-threatening complication after laparoscopic splenectomy (LS) in cirrhotic patients with hypersplenism. The mechanisms and risk factors of PVST are poorly understood. This study investigated risk factors for PVST following LS in cirrhotic patients with hypersplenism.
Materials and Methods:
A total of 56 consecutive cirrhotic patients with hypersplenism who underwent successful LS between 2013 and 2014 were included in this retrospective study. Based on the absence or presence of postoperative PVST on postoperative day (POD) 7, the patients were divided into non-PVST and PVST groups. Demographic and preoperative factors were analyzed.
Results:
PVST increased in size in 24 (42.9%) of 56 patients after LS on POD 7. Logistic multivariate regression showed that a portal vein diameter >13 mm (relative risk 35.796, 95% confidence interval 4.534–282.614, and P = .001) and age >50 years (relative risk 20.127, 95% confidence interval 3.598–112.578, and P = .001) were significant independent risk factors for PVST. The incidence of PVST after LS in the portal vein diameter >13 mm group was significantly higher than that in the portal vein diameter ≤13 mm group (P = .001). Similarly, the incidence of PVST after LS in the age >50 years group was significantly higher than that in the age ≤50 years group (P = .001).
Conclusion:
A portal vein diameter >13 mm and age >50 years are independent risk factors for PVST after LS in cirrhotic patients with hypersplenism due to portal hypertension.
JanssenHL, WijnhoudA, HaagsmaEB, et al.Extrahepatic portal vein thrombosis: Aetiology and determinants of survival. Gut, 2001; 49:720–724.
5.
CondatB, PessioneF, HillaireS, et al.Current outcome of portal vein thrombosis in adult: Risk and benefit of anticoagulant therapy. Gastroenterology, 2001; 120:490–497.
6.
Rodríguez-CastroKI, PorteRJ, NadalE, et al.Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: A systematic review. Transplantation, 2012; 94:1145–1153.
7.
FouzasI, PaulA, BeckerC, VernadakisS, et al.Orthotopic liver transplantation in patients with portal vein thrombosis in the absence of hepatocellular carcinoma. Transplant Proc, 2012; 44:2734–2736.
8.
WangM, ZhangM, LiJ, et al.Risk factors of portal vein thrombosis in patients with beta thalassemia major after splenectomy: Laparoscopic versus open procedure. Hepatogastroenterology, 2014; 61:48–54.
9.
LoringLA, PanicekDM, KarpehMS. Portal system thrombosis after splenectomy for neoplasm or chronic hematologic disorder: Is routine surveillance imaging necessary?. J Comput Assist Tomogr, 1998; 22:856–860.
10.
ChaffanjonPC, BrichonPY, RanchoupY, et al.Portal vein thrombosis following splenectomy for hematologic disease: Prospective study with Doppler color flow imaging. World J Surg, 1998; 22:1082–1086.
11.
SkarsgardE, DoskiJ, JaksicT, et al.Thrombosis of the portal venous system after splenectomy for pediatric hematologic disease. J Pediatr Surg, 1993; 28:1109–1112.
KinjoN, KawanakaH, AkahoshiT, et al.Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension. Br J Surg, 2010; 97:910–916.
14.
YoshidaM, WatanabeY, HoriuchiA, et al.Portal and splenic venous thrombosis after splenectomy in patients with hypersplenism. Hepatogastroenterology, 2009; 56:538–541.
15.
ZhangY, WenTF, YanLN, et al.Preoperative predictors of portal vein thrombosis after splenectomy with periesophagogastric devascularization. World J Gastroenterol, 2012; 18:1834–1839.
16.
WuS, WuZ, ZhangX, et al.The incidence and risk factors of portal vein system thrombosis after splenectomy and pericardial devascularization. Turk J Gastroenterol, 2015; 26:423–428.
17.
ZheC, Jian-weiL, JianC, et al.Laparoscopic versus open splenectomy and esophagogastric devascularization for bleeding varices or severe hypersplenism: A comparative study. J Gastrointest Surg, 2013; 17:654–659.
18.
IkedaM, SekimotoM, TakiguchiS, et al.High incidences of thrombosis of the portal venous system after laparoscopic splenectomy. Ann Surg, 2005; 241:208–216.
19.
BaiDS, QianJJ, ChenP, et al.Modified laparoscopic and open splenectomy and azygoportal disconnection for portal hypertension. Surg Endosc, 2014; 28:257–264.
20.
HanJ, YiY, DingH, et al.Preoperative risk factors of portal venous thrombosis after splenectomy and gastric pericardial devascularization for portal hypertension. Zhonghua Gan Zang Bing Za Zhi, 2014; 22:739–743.
21.
LiMX, ZhangXF, LiuZW, et al.Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis. Hepatobiliary Pancreat Dis Int, 2013; 12:512–519.
22.
LindbergF, RasmussenI, SiegbahnA, et al.Coagulation activation after laparoscopic cholecystectomy in spite of thromboembolism prophylaxis. Surg Endosc, 2000; 14:858–861.
23.
PietrabissaA, MorettoC, AntonelliG, et al.Thrombosis in the portal venous system after elective laparoscopic splenectomy. Surg Endosc, 2004; 18:1140–1143.
24.
ChengZ, YuF, TianJ, et al.A comparative study of two anti-coagulation plans on the prevention of PVST after laparoscopic splenectomy and esophagogastric devascularization. J Thromb Thrombolysis, 2015; 40:294–301.
25.
LaiW, LuSC, LiGY, et al.Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization. World J Gastroenterol, 2012; 18:3443–3450.
26.
VillaE, CammàC, MariettaM, et al.Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology, 2012; 143:1253–1260.
27.
HirookaM, IshidaK, KisakaY, et al.Efficacy of splenectomy for hypersplenic patients with advanced hepatocellular carcinoma. Hepatol Res, 2008; 38:1172–1177.
28.
SugawaraY, YamamotoJ, ShimadaK, et al.Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg, 2000; 190:446–450.
29.
ShimadaM, HashizumeM, ShirabeK, et al.A new surgical strategy for cirrhotic patients with hepatocellular carcinoma and hypersplenism. Performing a hepatectomy after a laparoscopic splenectomy. Surg Endosc, 2000; 14:127–130.
30.
HayashiPH, MehiaC, Joachim ReimersH, et al.Splenectomy for thrombocytopenia in patients with hepatitis C cirrhosis. J Clin Gastroenterol, 2006; 40:740–744.
31.
WangQ, SunK, LiXH, et al.Surgical treatment for hepatocellular carcinoma and secondary hypersplenism. Hepatobiliary Pancreat Dis Int, 2006; 5:396–400.
32.
ChenXP, WuZD, HuangZY, et al.Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism. Br J Surg, 2005; 92:334–339.
33.
ZhangXY, LiC, WenTF, et al.Synchronous splenectomy and hepatectomy for patients with hepatocellular carcinoma and hypersplenism: A casecontrol study. World J Gastroenterol, 2015; 21: 2358–2366.
34.
ZhuJ-H, WangY-D, YeZ-Y, et al.Laparoscopic versus open splenectomy for hypersplenism secondary to liver cirrhosis. Surg Laparosc Endosc Percutan Tech, 2009; 19:258–262.
